Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105

Nature Immunology

Volumn 6, Issue 6, 2005, Pages 571-578

  Divanovic, Senad ^a   Trompette, Aurelien ^a   Atabani, Sowsan F ^a   Madan, Rajat ^a   Golenbock, Douglas T ^b   Visintin, Alberto ^b   Finberg, Robert W ^b   Tarakhovsky, Alexander ^c   Vogel, Stefanie N ^d   Belkaid, Yasmine ^a   Kurt Jones, Evelyn A ^b   Karp, Christopher L ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD14 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; GLYCOPROTEIN P 15095; INTERLEUKIN 1; INTERLEUKIN 8; LEUKOCYTE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN RP105; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; CARRIER PROTEIN; CD180 PROTEIN, HUMAN; CELL SURFACE RECEPTOR; CYTOKINE; DNA; IMMUNOGLOBULIN RECEPTOR; LY78 PROTEIN, MOUSE; LY96 PROTEIN, HUMAN; MEMBRANE ANTIGEN; MEMBRANE PROTEIN; PROTEIN MD 2; RECOMBINANT PROTEIN; TLR4 PROTEIN, HUMAN; TLR4 PROTEIN, MOUSE; TOLL LIKE RECEPTOR;

ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CELL STRAIN HEK293; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LEUKOCYTE; LIGAND BINDING; MOUSE; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL LINE; CHEMISTRY; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; IN VITRO STUDY; INNATE IMMUNITY; METABOLISM; MOUSE MUTANT; NUCLEOTIDE SEQUENCE; PROTEIN TERTIARY STRUCTURE;

ANIMALS; ANTIGENS, CD; ANTIGENS, SURFACE; BASE SEQUENCE; CARRIER PROTEINS; CELL LINE; CYTOKINES; DENDRITIC CELLS; DNA; GENE EXPRESSION; HUMANS; IMMUNITY, NATURAL; LYMPHOCYTE ANTIGEN 96; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS; TRANSFECTION;

EID: 20644450101     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1198     Document Type: Article

References (52)

1. Medzhitov, R. & Janeway, C., Jr. Innate immune recognition: mechanisms and pathways. Immunol. Rev. 173, 89-97 (2000).
2. Takeda, K., Kaisho, T. & Akira, S. Toll-like receptors. Annu. Rev. Immunol. 21, 335-376 (2003).
3. Beutler, B. & Rietschel, E.T. Innate immune sensing and its roots: the story of endotoxin. Nat. Rev. Immunol. 3, 169-176 (2003).
4. Ardizzone, S. & Porro, G.B. Inflammatory bowel disease: new insights into pathogenesis and treatment. J. Intern. Med. 252, 475-496 (2002).
5. Bingham, C.O., III. The pathogenesis of rheumatoid arthritis: pivotal cytokines involved in bone degradation and inflammation. J. Rheumatol. Suppl. 65, 3-9 (2002).
6. Miyake, K., Yamashita, Y., Hitoshi, Y., Takatsu, K. & Kimoto, M. Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells. J. Exp. Med. 180, 1217-1224 (1994).
7. Miyake, K., Yamashita, Y., Ogata, M., Sudo, T. & Kimoto, M. RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family. J. Immunol. 154, 3333-3340 (1995).
8. Miura, Y. et al. Molecular cloning of a human RP105 homologue and chromosomal localization of the mouse and human RP105 genes (Ly64 and LY64). Genomics 38, 299-304 (1996).
9. Fugier-Vivier, I. et al. Molecular cloning of human RP105. Eur. J. Immunol. 27, 1824-1827 (1997).
10. Roshak, A.K. et al. Anti-human RP105 sera induces lymphocyte proliferation. J. Leukoc. Biol. 65, 43-49 (1999).
11. Shimazu, R. et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189, 1777-1782 (1999).
12. Miyake, K. et al. Mouse MD-1, a molecule that is physically associated with RP105 and positively regulates its expression. J. Immunol. 161, 1348-1353 (1998).
13. Miura, Y. et al. RP105 is associated with MD-1 and transmits an activation signal in human B cells. Blood 92, 2815-2822 (1998).
14. Nagai, Y. et al. Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide. Stood 99, 1699-1705 (2002).
15. Schneider, D.S., Hudson, K.L., Lin, T.Y. & Anderson, K.V. Dominant and recessive mutations define functional domains of Toll, a transmembrane protein required for dorsal-ventral polarity in the Drosophila embryo. Genes Dev. 5, 797-807 (1991).
16. Winans, K.A. & Hashimoto, C. Ventralization of the Drosophila embryo by deletion of extracellular leucine-rich repeats in the Toll protein. Mol. Biol. Cell 6, 587-596 (1995).
17. Medzhitov, R., Preston-Hurlburt, P. & Janeway, C.A., Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394-397 (1997).
18. Vogel, S.N. et al. Cutting edge: functional characterization of the effect of the C3H/HeJ defect in mice that lack an lpsn gene: In vivo evidence for a dominant negative mutation. J. Immunol. 162, 5666-5670 (1999).
19. Ronni, T. et al. Common interaction surfaces of the toll-like receptor 4 cytoplasmic domain stimulate multiple nuclear targets. Mol. Cell. 23, 2543-2555 (2003).
20. Jarrossay, D., Napolitani, G., Colonna, M., Sallusto, F. & Lanzavecchia, A. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur. J. Immunol. 31, 3388-3393 (2001).
21. Kadowaki, N. et al. Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194,863-869 (2001).
22. Krug, A. et al. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur. J. Immunol. 31, 3026-3037 (2001).
23. Latz, E. et al. Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the Toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J. Biol. Chem. 277, 47834-47843 (2002).
24. Kurt-Jones, E.A. et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1, 398-401 (2000).
25. Ogata, H. et al. The Toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells. J. Exp. Med. 192, 23-29 (2000).
26. Chan, V.W. et al. The molecular mechanism of B cell activation by Toll-like receptor protein RP-105. J. Exp. Med. 188, 93-101 (1998).
27. Yazawa, N. et al. CD19 regulates innate immunity by the Toll-like receptor RP105 signaling in B lymphocytes. Blood 102, 1374-1380 (2003).
28. Brint, E.K. et al. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat. Immunol. 5, 373-379 (2004).
29. Visintin, A., Latz, E., Monks, B.C., Espevik, T. & Golenbock, D.T. Lysines 128 and 132 enable lipopolysaccharide binding to MD-2, leading to Toll-like receptor-4 aggregation and signal transduction. J. Biol. Chem. 278, 48313-48320 (2003).
30. Tsuneyoshi, N. et al. The functional and structural properties of MD-2 required for lipopolysaccharide binding are absent in MD-1. J. Immunol. 174, 340-344 (2005).
31. + regulatory T cells control Leishmania major persistence and immunity. Nature 420, 502-507 (2002).
32. Hirschfeld, M., Ma, Y., Weis, J.H., Vogel, S.N. & Weis, J.J. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2. J. Immunol. 165, 618-622 (2000).
33. Wald, D. et al. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol. 4, 920-927 (2003).
34. Poltorak, A. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085-2088 (1998).
35. Rehli, M. Of mice and men: species variations of Toll-like receptor expression. Trends Immunol. 23, 375-378 (2002).
36. Cross, A.S. Endotoxin tolerance-current concepts in historical perspective. J. Endotoxin Res. 8, 83-98 (2002).
37. Kobayashi, K. et al. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110, 191-202 (2002).
38. Burns, K. et al. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J. Exp. Med. 197, 263-268 (2003).
39. Zhang, G. & Ghosh, S. Negative regulation of Toll-like receptor-mediated signaling by Tollip. J. Biol. Chem. 277, 7059-7065 (2002).
40. Watanabe, T., Kitani, A., Murray, P.J. & Strober, W. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat. Immunol. 5, 800-808 (2004).
41. Chuang, T.H. & Ulevitch, R.J. Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors. Nat. Immunol. 5, 495-502 (2004).
42. Akashi, S. et al. Cutting edge: cell surface expression and lipopolysaccharide signaling via the Toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages. J. Immunol. 164, 3471-3475 (2000).
43. Vogel, S.N., Fitzgerald, K.A. & Fenton, M.J. TLRs: Differential adapter utilization by Toll-like receptors mediates TLR-specific patterns of gene expression. Mol. Interv. 3, 466-477 (2003).
44. McIntire, F.C., Sievert, H.W., Barlow, G.H., Finley, R.A. & Lee, A.Y. Chemical, physical, biological properties of a lipopolysaccharide from Escherichia coli K-235. Biochemistry 6, 2363-2372 (1967).
45. Kurt-Jones, E.A. et al. Role of toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. Blood 100, 1860-1868 (2002).
46. Guidelines for the welfare of animals in rodent protection tests: a report from the Rodent Protection Test Working Party. Lab. Anim. 28, 13-18 (1994).
47. Karp, C.L. et al. Mechanism of suppression of cell-mediated immunity by measles virus. Science 273, 228-231 (1996).
48. Atabani, S.F. et al. Natural measles causes prolonged suppression of interleukin-12 production. J. Infect. Dis. 184, 1-9 (2001).
49. Jeanmougin, F., Thompson, J.D., Gouy, M., Higgins, D.G. & Gibson, T.J. Multiple sequence alignment with Clustal X. Trends Biochem. Sci. 23, 403-405 (1998).
50. Devereux, J., Haeberli, P. & Smithies, O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12, 387-395 (1984).
51. Jones, D.T., Taylor, W.R. & Thornton, J.M. A model recognition approach to the prediction of all-helical membrane protein structure and topology. Biochemistry 33, 3038-3049 (1994).
52. Hirokawa, T., Boon-Chieng, S. & Mitaku, S. SOSUI: classification and secondary structure prediction system for membrane proteins. Bioinformatics 14, 378-379 (1998).